Stifel Nicolaus downgrades Inverness Medical Innovations, Inc. (AMEX: IMA) from Buy to Hold, following its $90 takeover offer for Biosite ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE